AIMP2 and Parkinson disease: It has been reported that VPS35 expression is decreased in the brains of AD and PD patients.18, 19 Indeed, expression of PD-linked mutant VPS35 (D620N) led to similar effects to VPS35 knockdown on AIMP2 accumulation and AIMP2-related cellular toxicity.